Page last updated: 2024-09-03

efaproxiral and Benign Supratentorial Neoplasms

efaproxiral has been researched along with Benign Supratentorial Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carson, K; Gerber, M; Grossman, SA; Herman, T; Kleinberg, L; Lesser, G; O'Neill, A; Pearlman, J; Phillips, P1

Trials

1 trial(s) available for efaproxiral and Benign Supratentorial Neoplasms

ArticleYear
Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jul-15, Volume: 20, Issue:14

    Topics: Adult; Aged; Aniline Compounds; Chemotherapy, Adjuvant; Confidence Intervals; Drug Administration Schedule; Female; Glioblastoma; Humans; Male; Middle Aged; Propionates; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Supratentorial Neoplasms; Survival Analysis; Treatment Outcome; United States

2002